Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | S1PR1 | P21453 | 8/20 | 0.46 |
| ▸ | S1PR5 | Q9H228 | 8/20 | 0.46 |
| ▸ | S1PR3 | Q99500 | 6/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | GBA2 | Q9HCG7 | 1/20 | 0.41 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.40 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.40 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2345851 | 0.87 | SMN1; SMN2 (0.51) | LMNAPOLBSMN1; SMN2S1PR1S1PR5 | |
| SCHEMBL14159621 | 0.87 | SMN1; SMN2 (0.51) | LMNAPOLBSMN1; SMN2S1PR1S1PR5 | |
| SCHEMBL28253726 | 0.87 | SMN1; SMN2 (0.51) | LMNAPOLBSMN1; SMN2S1PR1S1PR5 | |
| SCHEMBL25326449 | 0.86 | LMNA (0.53) | LMNAPOLBSMN1; SMN2ALDH1A1GBA2 | |
| SCHEMBL5158334 | 0.86 | LMNA (0.53) | LMNAPOLBSMN1; SMN2ALDH1A1GBA2 | |
| SCHEMBL2357857 | 0.85 | SMN1; SMN2 (0.49) | LMNAPOLBSMN1; SMN2S1PR5ALDH1A1 | |
| SCHEMBL5495665 | 0.85 | SMN1; SMN2 (0.49) | LMNAPOLBSMN1; SMN2S1PR5ALDH1A1 | |
| SCHEMBL8303596 | 0.85 | SMN1; SMN2 (0.49) | LMNAPOLBSMN1; SMN2S1PR5ALDH1A1 | |
| SCHEMBL30816157 | 0.84 | LMNA (0.54) | LMNAPOLBSMN1; SMN2ALDH1A1GBA2 | |
| SCHEMBL27151384 | 0.84 | LMNA (0.54) | LMNAPOLBSMN1; SMN2ALDH1A1GBA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4326714-A1 | HETEROCYCLIC COMPOUNDS | F. Hoffmann-La Roche AG (CH) | 2024-02-28 | — | — | EP | disclosed |
| WO-2023144160-A1 | NEW HETEROCYCLIC COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2023-08-03 | — | — | WO | disclosed |
| WO-2023067354-A1 | HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER | ARTIOS PHARMA LIMITED (GB) | 2023-04-27 | — | — | WO | disclosed |
| EP-3665156-A1 | COMPOUNDS, COMPOSITIONS AND METHODS | Denali Therapeutics Inc. (US) | 2020-06-17 | — | — | EP | disclosed |
| WO-2019032743-A1 | COMPOUNDS, COMPOSITIONS AND METHODS | DENALI THERAPEUTICS INC. (US) | 2019-02-14 | — | — | WO | disclosed |
| EP-3201196-A1 | FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES | UCB Biopharma SPRL (BE) | 2017-08-09 | — | — | EP | disclosed |
| WO-2016050975-A1 | FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES | UCB BIOPHARMA SPRL (BE) | 2016-04-07 | — | — | WO | disclosed |
| EP-1747222-A1 | PYRIMIDINE DERIVATIVES ANTAGONISTS OF VITRONECTIN RECEPTOR | Proskelia SAS (FR) | 2007-01-31 | — | — | EP | disclosed |
| WO-2005123734-A1 | PYRIMIDINE DERIVATIVES ANTAGONISTS OF VITRONECTIN RECEPTOR | PROSKELIA SAS (FR) | 2005-12-29 | — | — | WO | disclosed |
| EP-1089964-A1 | HYDRAZINE DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2001-04-11 | — | — | EP | disclosed |
| WO-2000000465-A1 | HYDRAZINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2000-01-06 | — | — | WO | disclosed |
| EP-0874809-A1 | CARBAMOYLOXY DERIVATIVES OF MUTILINE AND THEIR USE AS ANTIBACTERIALS | SMITHKLINE BEECHAM PLC (GB) | 1998-11-04 | — | — | EP | disclosed |
| WO-1997025309-A1 | CARBAMOYLOXY DERIVATIVES OF MUTILINE AND THEIR USE AS ANTIBACTERIALS | SMITHKLINE BEECHAM PLC (GB) | 1997-07-17 | — | — | WO | disclosed |